{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:06:31Z","timestamp":1779451591695,"version":"3.53.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejogrb.2025.114903","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T16:01:00Z","timestamp":1766592060000},"page":"114903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Trends over years and maternal characteristics associated with use of recommended drugs during pregnancy: A cross-sectional study in France"],"prefix":"10.1016","volume":"318","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5589-3174","authenticated-orcid":false,"given":"Margaux","family":"Louchet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathis","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Treluyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Sibiude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Chouchana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2025.114903_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.611929","article-title":"Nutrition and metabolic adaptations in physiological and complicated pregnancy: focus on obesity and gestational diabetes","volume":"11","author":"Parrettini","year":"2020","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114903_b0010","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1017\/S0007114520001178","article-title":"Maternal use of folic acid and multivitamin supplements and infant risk of birth defects in Norway, 1999-2013","volume":"124","author":"Gildestad","year":"2020","journal-title":"Br J Nutr"},{"key":"10.1016\/j.ejogrb.2025.114903_b0015","doi-asserted-by":"crossref","unstructured":"Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. The Lancet. 1991;338(8760):131-137. doi:10.1016\/0140-6736(91)90133-A.","DOI":"10.1016\/0140-6736(91)90133-A"},{"key":"10.1016\/j.ejogrb.2025.114903_b0020","unstructured":"HAS. Projet de grossesse: informations, messages de pr\u00e9vention, examens \u00e0 proposer. Published online September 2009. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2010-01\/projet_de_grossesse_informations_messages_de_prevention_examens_a_proposer_-_argumentaire.pdf."},{"key":"10.1016\/j.ejogrb.2025.114903_b0025","unstructured":"WHO, World Health Organization. Periconceptional folic acid supplementation to prevent neural tube defects. Published online August 9, 2023. https:\/\/www.who.int\/tools\/elena\/interventions\/folate-periconceptional."},{"issue":"6","key":"10.1016\/j.ejogrb.2025.114903_b0030","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/1403494816649494","article-title":"Maternal use of folic acid supplements and infant risk of neural tube defects in Norway 1999-2013","volume":"44","author":"Gildestad","year":"2016","journal-title":"Scand J Public Health"},{"issue":"26","key":"10.1016\/j.ejogrb.2025.114903_b0035","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJM199212243272602","article-title":"Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation","volume":"327","author":"Czeizel","year":"1992","journal-title":"N Engl J Med"},{"issue":"6893","key":"10.1016\/j.ejogrb.2025.114903_b0040","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1136\/bmj.306.6893.1645","article-title":"Prevention of congenital abnormalities by periconceptional multivitamin supplementation","volume":"306","author":"Czeizel","year":"1993","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ejogrb.2025.114903_b0045","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.2024.13546","article-title":"Screening and supplementation for iron deficiency and iron deficiency anemia during pregnancy: updated evidence report and systematic review for the US preventive services task force","volume":"332","author":"Cantor","year":"2024","journal-title":"J Am Med Assoc"},{"issue":"12","key":"10.1016\/j.ejogrb.2025.114903_b0050","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1093\/jn\/133.12.4139","article-title":"Low hemoglobin level is a risk factor for postpartum depression","volume":"133","author":"Corwin","year":"2003","journal-title":"J Nutr"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114903_b0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1552-6909.1999.tb01983.x","article-title":"Longitudinal changes in fatigue and energy during pregnancy and the postpartum period","volume":"28","author":"Lee","year":"1999","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114903_b0060","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3390\/nu12020447","article-title":"Iron deficiency and iron deficiency anemia: implications and impact in pregnancy, fetal development, and early childhood parameters","volume":"12","author":"Means","year":"2020","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.ejogrb.2025.114903_b0065","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1093\/jn\/134.10.2586","article-title":"Preconception hemoglobin and ferritin concentrations are associated with pregnancy outcome in a prospective cohort of Chinese women","volume":"134","author":"Ronnenberg","year":"2004","journal-title":"J Nutr"},{"key":"10.1016\/j.ejogrb.2025.114903_b0070","unstructured":"WHO, World Health Organization. Pregnant women must be able to access the right care at the right time, says WHO. Published online November 7, 2016. https:\/\/www.who.int\/news\/item\/07-11-2016-pregnant-women-must-be-able-to-access-the-right-care-at-the-right-time-says-who."},{"key":"10.1016\/j.ejogrb.2025.114903_b0075","unstructured":"Coll\u00e8ge National des Gyn\u00e9cologues et Obst\u00e9triciens Fran\u00e7ais. Recommandations pour la pratique clinique. Suppl\u00e9mentation au cours de la grossesse. Published online December 5, 1997. https:\/\/cngof.fr\/app\/pdf\/RPC\/\/1-RPC%20DU%20CNGOF\/1997\/RPC_suppl_97.pdf?x94059."},{"key":"10.1016\/j.ejogrb.2025.114903_b0080","unstructured":"HAS, Haute Autorit\u00e9 de Sant\u00e9. Commission de la transparence. Avis. 15 mai 2013. UVEDOSE 100 000 UI, solution buvable en ampoule. Published online May 15, 2023. https:\/\/www.has-sante.fr\/upload\/docs\/evamed\/CT-12890_UVEDOSE_RI_Avis1_CT12890.pdf."},{"key":"10.1016\/j.ejogrb.2025.114903_b0085","unstructured":"WHO, World Health Organization. Vitamin D supplementation during pregnancy. Published online August 9, 2023. https:\/\/www.who.int\/tools\/elena\/interventions\/vitamind-supp-pregnancy."},{"issue":"6","key":"10.1016\/j.ejogrb.2025.114903_b0090","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.banm.2021.04.004","article-title":"Rapport 21\u201303. Il faut vacciner les femmes enceintes contre la grippe et contre la coqueluche","volume":"205","author":"Buisson","year":"2021","journal-title":"Bulletin de l\u2019Acad\u00e9mie Nationale de M\u00e9decine"},{"key":"10.1016\/j.ejogrb.2025.114903_b0095","unstructured":"Centers for Disease Control and Prevention (CDC). Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1)--United States, April 2009-August 2010. MMWR Morb Mortal Wkly Rep. 2011;60(35):1193-1196."},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114903_b0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajog.2010.12.033","article-title":"2009 pandemic influenza a (H1N1) in pregnancy: a systematic review of the literature","volume":"205","author":"Mosby","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2025.114903_b0105","unstructured":"WHO, World Health Organization. Influenza vaccination of women during pregnancy. Published online December 3, 2003. https:\/\/www.who.int\/groups\/global-advisory-committee-on-vaccine-safety\/topics\/influenza-vaccines\/pregnancy#cms."},{"key":"10.1016\/j.ejogrb.2025.114903_b0110","unstructured":"ACOG. Influenza in Pregnancy Prevention and Treatment. 2025. Accessed December 13, 2025. https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2025\/08\/influenza-in-pregnancy-prevention-and-treatment."},{"key":"10.1016\/j.ejogrb.2025.114903_b0115","unstructured":"ACOG. COVID-19 Vaccines and Pregnancy: Conversation Guide for Clinicians. 2025. Accessed December 13, 2025. https:\/\/www.acog.org\/programs\/immunization-infectious-disease-public-health\/tools-and-resources\/covid-19-vaccines-and-pregnancy-conversation-guide-for-clinicians."},{"issue":"9","key":"10.1016\/j.ejogrb.2025.114903_b0120","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/pds.4577","article-title":"Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015","volume":"27","author":"Engeland","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"10.1016\/j.ejogrb.2025.114903_b0125","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.3390\/ijerph19074186","article-title":"Drug Prescriptions among Italian and immigrant pregnant women resident in italy: a cross-sectional population-based study","volume":"19","author":"D\u2019Aloja","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ejogrb.2025.114903_b0130","doi-asserted-by":"crossref","DOI":"10.4414\/SMW.2021.w30048","article-title":"Use of drugs to treat symptoms and acute conditions during pregnancy in outpatient care in Switzerland between 2014 and 2018: analysis of Swiss healthcare claims data","volume":"151","author":"Gerbier","year":"2021","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114903_b0135","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12884-024-06283-8","article-title":"Preconception folic acid supplementation for the prevention of birth defects: a prospective, population-based cohort study in mainland China","volume":"24","author":"Zhou","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"issue":"8","key":"10.1016\/j.ejogrb.2025.114903_b0140","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-071335","article-title":"Drug exposure during pregnancy in primary care: an algorithm and observational study from SIDIAP database, Catalunya, Spain","volume":"13","author":"Lest\u00f3n V\u00e1zquez","year":"2023","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.ejogrb.2025.114903_b0145","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/pds.5299","article-title":"Using administrative healthcare database records to study trends in prescribed medication dispensed during pregnancy in Belgium from 2003 to 2017","volume":"30","author":"Larcin","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"10.1016\/j.ejogrb.2025.114903_b0150","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5694\/mja2.50125","article-title":"Influenza and pertussis vaccination of women during pregnancy in Victoria, 2015-2017","volume":"210","author":"Rowe","year":"2019","journal-title":"Med J Aust"},{"issue":"11","key":"10.1016\/j.ejogrb.2025.114903_b0155","doi-asserted-by":"crossref","first-page":"528","DOI":"10.5694\/mja2.51989","article-title":"Influenza and pertussis vaccine coverage in pregnancy in Australia, 2016-2021","volume":"218","author":"McRae","year":"2023","journal-title":"Med J Aust"},{"issue":"7","key":"10.1016\/j.ejogrb.2025.114903_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219095","article-title":"The French pregnancy cohort: medication use during pregnancy in the French population","volume":"14","author":"B\u00e9rard","year":"2019","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.ejogrb.2025.114903_b0165","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/pds.4265","article-title":"Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample","volume":"26","author":"Demailly","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114903_b0170","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.therap.2020.07.002","article-title":"Drug prescriptions in French pregnant women between 2015 and 2016: a study in the EGB database","volume":"76","author":"Araujo","year":"2021","journal-title":"Therapie"},{"key":"10.1016\/j.ejogrb.2025.114903_b0175","doi-asserted-by":"crossref","unstructured":"Pouchieu C, L\u00e9vy R, Faure C, et al. Socioeconomic, Lifestyle and Dietary Factors Associated with Dietary Supplement Use during Pregnancy. Hawkins SM, ed. PLoS ONE. 2013;8(8):e70733. doi: 10.1371\/journal.pone.0070733.","DOI":"10.1371\/journal.pone.0070733"},{"issue":"7","key":"10.1016\/j.ejogrb.2025.114903_b0180","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/aogs.12656","article-title":"Maternal folic acid supplementation trends 2009\u20132013","volume":"94","author":"McKeating","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"10","key":"10.1016\/j.ejogrb.2025.114903_b0185","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1017\/S0007114521004840","article-title":"Prenatal folic acid supplementation and folate status in early pregnancy: ECLIPSES study","volume":"128","author":"Iglesias-V\u00e1zquez","year":"2022","journal-title":"Br J Nutr"},{"issue":"18","key":"10.1016\/j.ejogrb.2025.114903_b0190","first-page":"6094","article-title":"The role of education and migration background in explaining differences in folic acid supplementation intake in pregnancy: results from a German birth cohort study","volume":"24","author":"Miani","year":"2021","journal-title":"Public HealthNutr"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.114903_b0195","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.therap.2023.01.009","article-title":"Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): how to translate guidelines into practice","volume":"78","author":"de Germay","year":"2023","journal-title":"Therapie"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114903_b0200","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213933","article-title":"Trends in prenatal exposure to antiseizure medications over the past decade: a nationwide study","volume":"105","author":"Shahriari","year":"2025","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114903_b0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295897","article-title":"Trends in harmful drug exposure during pregnancy in France between 2013 and 2019: a nationwide cohort study","volume":"19","author":"Louchet","year":"2024","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ejogrb.2025.114903_b0210","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/pds.4556","article-title":"Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: an application to antiepileptic drug use in 4.9 million pregnant women in France","volume":"27","author":"Bloti\u00e8re","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ejogrb.2025.114903_b0215","unstructured":"HAS. Projet de grossesse: informations, messages de pr\u00e9vention, examens \u00e0 proposer.; 2010. Accessed December 13, 2025. https:\/\/www.has-sante.fr\/jcms\/c_1360649\/fr\/projet-de-grossesse-informations-messages-de-prevention-examens-a-proposer."},{"key":"10.1016\/j.ejogrb.2025.114903_b0220","unstructured":"HCSP. Vaccination contre la grippe saisonni\u00e8re. Actualisation des recommandations\u00a0: femmes enceintes et personnes ob\u00e8ses. Haut Conseil de la Sant\u00e9 Publique; 2012. Accessed December 13, 2025. https:\/\/www.hcsp.fr\/explore.cgi\/avisrapportsdomaine?clefr=260."},{"issue":"11","key":"10.1016\/j.ejogrb.2025.114903_b0225","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/jech-2011-200311","article-title":"Construction of an adaptable European transnational ecological deprivation index: the French version","volume":"66","author":"Pornet","year":"2012","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.ejogrb.2025.114903_b0230","doi-asserted-by":"crossref","unstructured":"Blangis F, Drouin J, Launay E, et al. Maternal, prenatal and postnatal risk factors for early child physical abuse: a French nationwide cohort study. The Lancet Regional Health - Europe. Published online 2024:100921. doi:10.1016\/j.lanepe.2024.100921.","DOI":"10.1016\/j.lanepe.2024.100921"},{"key":"10.1016\/j.ejogrb.2025.114903_b0235","unstructured":"D\u00e9cret N\u00b0 2016-1871 Du 26 D\u00e9cembre 2016 Relatif Au Traitement de Donn\u00e9es \u00e0 Caract\u00e8re Personnel D\u00e9nomm\u00e9 \u00ab\u00a0syst\u00e8me National Des Donn\u00e9es de Sant\u00e9\u00a0\u00bb.; 2016. Accessed December 13, 2025. https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000033702840."},{"key":"10.1016\/j.ejogrb.2025.114903_b0240","unstructured":"SPF. Enqu\u00eate nationale p\u00e9rinatale. Rapport 2021.; 2021. Accessed December 13, 2025. https:\/\/www.santepubliquefrance.fr\/import\/enquete-nationale-perinatale.-rapport-2021.-les-naissances-le-suivi-a-deux-mois-et-les-etablissements."},{"key":"10.1016\/j.ejogrb.2025.114903_b0245","unstructured":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9 A.N.S.M. Enceinte, les m\u00e9dicaments, c\u2019est pas n\u2019importe comment! Published online June 1, 2021. https:\/\/ansm.sante.fr\/dossiers-thematiques\/medicaments-et-grossesse."},{"issue":"7\u20138","key":"10.1016\/j.ejogrb.2025.114903_b0250","first-page":"573","article-title":"Factors associated with inadequate folic acid supplementation for the prevention of neural tube defects in eight Parisian maternity units","volume":"49","author":"Rousseau","year":"2021","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.114903_b0255","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.2023.9864","article-title":"Folic acid supplementation to prevent neural tube defects: updated evidence report and systematic review for the US preventive services task force","volume":"330","author":"Viswanathan","year":"2023","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.114903_b0260","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3390\/nu11051108","article-title":"Social Inequalities in prenatal folic acid supplementation: results from the ELFE cohort","volume":"11","author":"Camier","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114903_b0265","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1186\/s12889-018-5545-z","article-title":"Drug prescribing during pregnancy in a central region of Italy, 2008-2012","volume":"18","author":"Ventura","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ejogrb.2025.114903_b0270","doi-asserted-by":"crossref","unstructured":"Subramanian A, Azcoaga-Lorenzo A, Anand A, et al. Polypharmacy during pregnancy andassociated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019. BMC Med. 2023;21(1):21. doi:10.1186\/s12916-022-02722-5.","DOI":"10.1186\/s12916-022-02722-5"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.114903_b0275","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/bcp.15638","article-title":"Trends in anti-infective use during pregnancy in France between 2010 and 2019: a nationwide population-based study","volume":"89","author":"Tubiana","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ejogrb.2025.114903_b0280","unstructured":"Vaux sophie, Gautier A, Soullier N, Le Masne A, Bonmarin I, Parent du Ch\u00e2telet I. Couverture vaccinale contre la grippe des femmes enceintes, propositions de vaccination et \u00e9tude des d\u00e9terminants, France m\u00e9tropolitaine, 2019-2021. Published online January 18, 2023. https:\/\/beh.santepubliquefrance.fr\/beh\/2023\/17\/pdf\/2023_17_3.pdf."},{"issue":"5","key":"10.1016\/j.ejogrb.2025.114903_b0285","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1080\/21645515.2019.1688035","article-title":"Seasonal influenza vaccine uptake and vaccine refusal among pregnant women in France: results from a national survey","volume":"16","author":"Descamps","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114903_b0290","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00431-022-04733-z","article-title":"Determinants of incomplete vaccination in children at age two in France: results from the nationwide ELFE birth cohort","volume":"182","author":"Jacques","year":"2023","journal-title":"Eur J Pediatr"},{"issue":"38","key":"10.1016\/j.ejogrb.2025.114903_b0295","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.15585\/mmwr.mm6638a2","article-title":"Influenza vaccination coverage among pregnant women - United States, 2016-17 influenza season","volume":"66","author":"Ding","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"19","key":"10.1016\/j.ejogrb.2025.114903_b0300","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.vaccine.2018.03.033","article-title":"Coverage of recommended vaccines during pregnancy in Flanders, Belgium. Fairly good but can we do better?","volume":"36","author":"Maertens","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ejogrb.2025.114903_b0305","unstructured":"Public Health Agency of Canada. Folic acid, healthy pregnancy and neural tube defect prevention. January 5, 2018. Accessed December 13, 2025. https:\/\/www.canada.ca\/en\/public-health\/services\/pregnancy\/folic-acid.html."},{"key":"10.1016\/j.ejogrb.2025.114903_b0310","unstructured":"NHS. Vitamins, supplements and nutrition in pregnancy. Published online February 2, 2023. https:\/\/www.nhs.uk\/pregnancy\/keeping-well\/vitamins-supplements-and-nutrition\/."},{"key":"10.1016\/j.ejogrb.2025.114903_b0315","unstructured":"Ministerio de sanidad. Gu\u00eda de pr\u00e1ctica cl\u00ednica de atenci\u00f3n en el embarazo y puerperio. Published online 2014. https:\/\/www.sanidad.gob.es\/va\/organizacion\/sns\/planCalidadSNS\/pdf\/GPC_de_embarazo_y_puerperio.pdf."},{"key":"10.1016\/j.ejogrb.2025.114903_b0320","unstructured":"German Federal Institues of Risk Assessment. Pregnant people. November 29, 2023. Accessed December 13, 2025. https:\/\/www.bfr.bund.de\/en\/about-us\/risk-assessment\/pregnant-people\/."},{"key":"10.1016\/j.ejogrb.2025.114903_b0325","unstructured":"Istituto Superiore di Sanit\u00e0. Policies on folic acid: the Italian position. https:\/\/m.bfr-meal-studie.de\/cm\/343\/policies_on_folic_acid_the_italian_position.pdf."},{"key":"10.1016\/j.ejogrb.2025.114903_b0330","unstructured":"Institute of Medicine (US) Committee on Nutritional Status During Pregnancy and Lactation., Washington (DC). Nutrition During Pregnancy: Part I Weight Gain: Part II Nutrient Supplements."},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114903_b0335","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1590\/S1415-790X2013000300016","article-title":"Iron supplementation among pregnant women: results from a population-based survey study","volume":"16","author":"Cesar","year":"2013","journal-title":"Rev Bras Epidemiol"},{"key":"10.1016\/j.ejogrb.2025.114903_b0340","unstructured":"British Society for Haematology. UK guidelines on the management of iron deficiency in pregnancy. Published online January 28, 2021. https:\/\/b-s-h.org.uk\/guidelines\/guidelines\/uk-guidelines-on-the-management-of-iron-deficiency-in-pregnancy."},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114903_b0345","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s12884-018-2130-5","article-title":"Iron supplementation during pregnancy \u2013 a cross-sectional study undertaken in four German states","volume":"18","author":"Demuth","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ejogrb.2025.114903_b0350","unstructured":"Kunskapsstod for vardgivare. Anemiscreening och j\u00e4rntillskott. Published online August 2025. https:\/\/kunskapsstodforvardgivare.se\/omraden\/kvinnosjukdomar-och-forlossning\/riktlinjer-bmm\/barnmorskemottagning\/graviditet\/riktlinjer\/anemiscreening-och-jarntillskott."},{"key":"10.1016\/j.ejogrb.2025.114903_b0355","unstructured":"Norwegian Directorate of Healt helsedirektoratet. Gravide b\u00f8r i f\u00f8rste trimester f\u00e5 tilbud om m\u00e5ling av serumferritin for vurdering av jernstatus og r\u00e5d om jerntilskudd. 2021. Accessed December 13, 2025. https:\/\/www.helsedirektoratet.no\/retningslinjer\/svangerskapsomsorgen\/rutinemalinger-i-blodet-til-gravide\/gravide-bor-i-forste-trimester-fa-tilbud-om-maling-av-serumferritin-for-vurdering-av-jernstatus-og-rad-om-jerntilskudd."},{"issue":"662","key":"10.1016\/j.ejogrb.2025.114903_b0360","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3399\/bjgp17X692489","article-title":"Vitamin D supplementation for women before and during pregnancy: an update of the guidelines, evidence, and role of GPs and practice nurses","volume":"67","author":"Hynes","year":"2017","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.ejogrb.2025.114903_b0365","unstructured":"Eneroth H, Julin B. D-vitamin under graviditet och amning En litteraturstudie om status, intag och samband med h\u00e4lsa. Published online 2018. https:\/\/www.livsmedelsverket.se\/49e113\/globalassets\/publikationsdatabas\/rapporter\/2018\/D-vitamin-under-graviditet-och-amning-livsmedelsverket-nr-7-2018\/."},{"key":"10.1016\/j.ejogrb.2025.114903_b0370","unstructured":"Candiani G, Daghini R. Gravidanza fisiologica. Published online settembre 2011. https:\/\/www.epicentro.iss.it\/materno\/pdf\/LG_Gravidanza.pdf."},{"key":"10.1016\/j.ejogrb.2025.114903_b0375","doi-asserted-by":"crossref","unstructured":"ACOG Committee Opinion No. 495: Vitamin D: Screening and supplementation during pregnancy. Obstet Gynecol. 2011;118(1):197-198. doi:10.1097\/AOG.0b013e318227f06b.","DOI":"10.1097\/AOG.0b013e318227f06b"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114903_b0380","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004365","article-title":"Medication use in pregnancy: a cross-sectional, multinational web-based study","volume":"4","author":"Lupattelli","year":"2014","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.114903_b0385","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048092","article-title":"Maternal over-the-counter analgesics use during pregnancy and adverse perinatal outcomes: cohort study of 151\u2009141 singleton pregnancies","volume":"12","author":"Zafeiri","year":"2022","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114903_b0390","first-page":"272","article-title":"Prevalence and reasons of self-medication in pregnant women: a systematic review and meta-analysis","volume":"6","author":"Mohseni","year":"2018","journal-title":"Int J Community Based Nurs Midwifery"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.114903_b0395","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/AOG.0000000000002579","article-title":"Prescription and other medication use in pregnancy","volume":"131","author":"Haas","year":"2018","journal-title":"Obstet Gynecol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525011790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525011790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:20:06Z","timestamp":1779448806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211525011790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":79,"alternative-id":["S0301211525011790"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114903","relation":{"has-preprint":[{"id-type":"doi","id":"10.22541\/au.173461330.02479899\/v1","asserted-by":"object"}]},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends over years and maternal characteristics associated with use of recommended drugs during pregnancy: A cross-sectional study in France","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114903"}}